Genetic Intelligence - Genetic Leap blog

Sign in Subscribe

Genetic Intelligence

Welcome to Larry Senour

Welcome to Larry Senour

We are excited to welcome Larry Senour to Genetic Intelligence to help lead business development. Larry has 30 years of healthcare experience in strategy, operations and transaction roles, including 23 years with Merck & Co., Inc. In his last role at Merck he was Managing Director of Healthcare Services &

VIDEO: Experience Genetic Intelligence

VIDEO: Experience Genetic Intelligence

Watch the Genetic Intelligence vision. Genetic Intelligence finds truly causal disease targets and designs medicines to fix them. With Genetic Intelligence, you can step into the future of drug discovery. You can take in all of the interconnected parts of your program in full clarity. You can drive better collaboration,

5,000 Alzheimer's disease WGS Access

5,000 Alzheimer's disease WGS Access

Genetic Intelligence access to 5,000 AD WGS

Shifting perspectives on our WGS and lower sample numbers focus

Shifting perspectives on our WGS and lower sample numbers focus

Increasingly, we are seeing the genetic field slowly pivot toward the path we at GI have insisted on (and blazed) all along. Namely, 1) whole genome (WGS) instead of whole exome (WES) and 2) well characterized cohorts (which can mean smaller number of samples) instead of larger and larger studies.

Genetic Intelligence awarded Competitive grant from the National Science Foundation

Genetic Intelligence awarded Competitive grant from the National Science Foundation

Genetic Intelligence has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to conduct research and development (R&D) work on causal disease gene identification from Whole Genomes using Artificial Intelligence

Welcome to the Genetic Intelligence Brief

Getting Started

Welcome to the Genetic Intelligence Brief

The GI Brief is designed to be concise, accessible, and bearer of answers. Let's jump in.